Answers are grounded in this paper and cite their sources.
Background Metastasis is the leading cause of cancer-associated death. p53 mutants promote metastasis, yet the underlying mechanisms have not been clearly elucidated. Drugs that target mutant p53-driven metastasis are needed. This study aimed to identify low-toxicity small-molecule compounds targeting mutant p53-driven metastasis and elucidate the underlying molecular mechanisms. Methods The migration and invasion abilities of the cells were examined by wound healing and Transwell assays. Two machine learning models, XGBoost with SHAP interpretation and MetaNet, were employed to assess the key drivers of mutant p53-associated metastasis. RNA-seq, immunofluorescence staining (IF), coimmunoprecipitation (co-IP), microscale thermophoresis (MST), and drug affinity responsive target stability (DARTS) were used to elucidate the targets and mechanism of action of manglisin A (MA). Zebrafish and murine xenograft models were used to explore the effects of MA in vivo . Results High-throughput wound-healing-based screening was carried out within a natural product library of 647 compounds, and MA was identified to inhibit mutant p53-driven migration and invasion. RNA-seq analysis revealed the PI3K pathway as a key pathway in mutant p53-associated metastasis, which was further supported by SHAP analysis and data from MetaNet. Mechanistically, MA inhibited EMT and metastasis through the mutant p53-PIP5K1A-FAK/Src pathway. Mutant p53 recruited PIP5K1A to the leading edge of the cell membrane in migratory cells, whereas MA disrupted this interaction, further promoting the degradation of PIP5K1A and mutant p53. Moreover, tumors harboring mutant p53 with high PIP5K1A expression are associated with poor prognosis. MA suppressed mutant p53-driven tumor metastasis in vivo . Conclusion Our study highlights the mutant p53-PIP5K1A complex as a potential therapeutic target for metastasis and MA as a potential lead compound for targeting mutant p53-driven metastasis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: